NGNE
NGNE
NASDAQ · Biotechnology

Neurogene Inc

$28.56
+0.25 (+0.88%)
As of Sep 28, 2:31 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -12.0% upside
Low Target $17.03
Average Target $25.14
High Target $37.02
Current Price $28.56
Current
$28.56
Target
$25.14
$17.03 $25.14 avg $37.02
Scenario Analysis
Bear Case
$17.03
-40.4%
Low target
Base Case
$25.14
-12.0%
Avg target
Bull Case
$37.02
+29.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$43.66
-34.6% from high
52-Week Low
$15.93
+79.3% from low
Target vs 52W High
$25.14
-42.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%